Related Experiment Video
Updated: May 12, 2026

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
Fecal S100A12: identifying intestinal distress in very-low-birth-weight infants
Jan Däbritz1, Dirk Foell, Stefan Wirth
1Royal Children's Hospital Melbourne, Murdoch Children's Research Institute, Parkville, Australia. Jan.Daebritz@uni-muenster.de
Insights
Fecal S100A12 levels are elevated in very-low-birth-weight (VLBW) infants experiencing intestinal distress. However, its utility as an early biomarker is limited by overlapping values with healthy infants.
Area of Science:
- Neonatal Medicine
- Gastroenterology
- Biomarker Research
Background:
- Intestinal distress is a significant concern in very-low-birth-weight (VLBW) infants.
- Identifying reliable biomarkers for early detection is crucial for timely intervention.
- S100A12, a damage-associated molecular pattern protein, is implicated in inflammatory processes.
Purpose of the Study:
- To investigate if longitudinal fecal S100A12 measurements can identify VLBW infants at risk for intestinal distress.
- To differentiate intestinal distress from necrotizing enterocolitis using fecal S100A12.
- To assess the potential of fecal S100A12 as an early diagnostic marker.
Main Methods:
- Prospective study involving 46 VLBW infants with intestinal distress and 49 controls.
- Collection of meconium and stool samples every alternate day for 4 weeks.
- Quantification of fecal S100A12 using enzyme-linked immunosorbent assay (ELISA).
Main Results:
- VLBW infants with intestinal distress had significantly lower birth weight and gestational age.
- Fecal S100A12 levels were significantly higher in infants with intestinal distress before and at disease onset.
- A cutoff of 60 μg/kg showed 73% sensitivity and 55% specificity for detecting distress within 7 days prior.
- S100A12 levels normalized within 2 weeks post-onset.
Conclusions:
- Fecal S100A12 is elevated in VLBW infants with intestinal distress.
- The diagnostic potential of S100A12 as an early biomarker is constrained by significant overlap with reference values.
- Further research may be needed to refine its use in clinical settings.
Objectives:
The aim of the study was to determine whether longitudinal measurements of fecal S100A12, a damage-associated molecular pattern protein, which is released from neutrophils or monocytes under stress, can detect very-low-birth-weight (VLBW) infants at risk for intestinal distress apart from necrotizing enterocolitis.
Methods:
This prospective study included 46 VLBW infants with intestinal distress and 49 reference patients. Meconium and stool samples were collected prospectively on alternate days for 4 weeks, and fecal S100A12 was measured by enzyme-linked immunosorbent assay.
Results:
Gestational age and weight at birth were significantly lower in patients with intestinal distress when compared to unaffected reference infants. Median levels of fecal S100A12 were significantly higher in patients with intestinal distress at onset of disease and before compared with unaffected reference infants. Median levels of fecal S100A12 declined steadily to baseline levels within 2 weeks after disease onset. The ideal cutoff value for identifying patients with intestinal distress within 7 days before disease onset was 60 μg/kg (sensitivity 0.73; specificity 0.55).
Conclusions:
Fecal S100A12 levels are increased in VLBW infants with intestinal distress; however, the potential for S100A12 as an early biomarker is largely limited by overlaps between values of infants with intestinal distress and the reference population.
More Related Videos
07:18Oral Gavage in Neonatal Mouse Pups and Functional Assessment of Gut Barrier Integrity Using Ussing Chambers
Published on: January 9, 2026
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Intestinal Obstruction II: Pathophysiology
Serum Laboratory Studies, Stool Test, Breath Test